Email updates

Keep up to date with the latest news and content from Retrovirology and BioMed Central.

This article is part of the supplement: Abstracts from the 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID)

Open Access Open Badges Poster presentation

Three-dimensional modeling of DCIR and identification of new drugs blocking HIV-1 attachment and propagation

Caroline Gilbert*, Arezki Azzi, Alexandra A Lambert, Sheng-Xiang Lin, Geneviève Allaire, Karianne P St-Gelais and Michel J Tremblay

Author Affiliations

Laval University, Québec, Canada

For all author emails, please log on.

Retrovirology 2012, 9(Suppl 1):P9  doi:10.1186/1742-4690-9-S1-P9

The electronic version of this article is the complete one and can be found online at:

Published:25 May 2012

© 2012 Gilbert et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The HIV-1 pandemic continues to expand while no effective vaccine is yet available. Finding new therapeutic targets and drugs is therefore crucial. We have previously shown that the dendritic cell immunoreceptor (DCIR), a C-type lectin receptor expressed in dendritic cells (DCs), acts as an attachment factor for HIV-1 to DCs and contributes to HIV-1 transmission to CD4+ T lymphocytes (CD4TL). Directly involved in HIV-1 infection, DCIR is expressed in apoptotic or infected CD4TL and promotes trans-infection to bystander cells. The aim of the present study is to characterize the extracellular domain of DCIR and to test chemical inhibitors of HIV-1 attachment thereto.


We present the first three-dimensional model of DCIR structure. Based on this structure, several inhibitors were selected to target viral interaction with the carbohydrate recognition domain and the EPS motif. Preliminary screening using Raji-CD4-DCIR cells identified two inhibitors that decreased HIV-1 attachment and propagation. These inhibitors did not affect the proliferation of peripheral blood mononuclear cells.


The results of this study thus suggest structures for novel molecules capable of blocking HIV-1 transmission by DCs and CD4TL.